Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A pharmacokinetics (PK) study of ZL-2306 in Chinese patients with platinum-sensitive ovarian cancer

Trial Profile

A pharmacokinetics (PK) study of ZL-2306 in Chinese patients with platinum-sensitive ovarian cancer

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Niraparib (Primary)
  • Indications Ovarian cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 16 Mar 2020 According to Zai Lab maedia release, this study was published in August 2019 in The Oncologist.
    • 30 May 2018 New trial record
    • 21 May 2018 According to Zai Lab maedia release, company has successfully completed enrollment three months ahead of schedule and expect to finalize the data from this study by mid-2018, also earlier than planned.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top